A large 60-year study of 1388 MS patients, done in Norway, ended in 2012. The abstract of the paper on this study, entitled "Survival and mortality in multiple sclerosis: A 60-year longitudinal population study," appeared in PubMed, April 4, 2017:
Only registered and activated users can see links., Click Here To Register...
Maybe surprisingly, in spite of the disease-modifying drugs, the life expectancy remained static, still about 7 years shorter than for the general population. However, the results are interpreted optimistically in an article in MedPage Today (April 11):
Only registered and activated users can see links., Click Here To Register...
Only registered and activated users can see links., Click Here To Register...
Maybe surprisingly, in spite of the disease-modifying drugs, the life expectancy remained static, still about 7 years shorter than for the general population. However, the results are interpreted optimistically in an article in MedPage Today (April 11):
Only registered and activated users can see links., Click Here To Register...

s
Comment